» Authors » Nuran Sari

Nuran Sari

Explore the profile of Nuran Sari including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Saricaoglu E, Basaran S, Seyman D, Arslan M, Ozkan-Ozturk S, Tezer-Tekce Y, et al.
Eur J Clin Microbiol Infect Dis . 2025 Mar; PMID: 40085380
Purpose: Infective endocarditis (IE) is a evolving disease with a shifting epidemiology and disease burden over time. This study aimed to compare the epidemiological and clinical aspects of IE over...
2.
Sari N, Baci B, Canli M, Cinar O, Durgut S, Olcar Z, et al.
Exp Clin Transplant . 2025 Feb; 23(1):60-66. PMID: 39918194
Objectives: Solid-organ transplant recipients are prone to infections due to intensive immunosuppression treatments after transplant. Incidence of viral infections is gradually increasing. During the COVID-19 pandemic, transplant patients were shown...
3.
Esendagli D, Sari N, Akhan S, Arslan S, Dogan Ontas I, Yilmaz G, et al.
Med Princ Pract . 2025 Jan; :1-10. PMID: 39870064
Objective: We are still in search of new therapeutic options for COVID-19 to prevent new infections, enable fast recovery, and reduce the long-lasting symptoms or sequelae. This study aimed to...
4.
Erol C, Sari N, Yanik-Yalcin T, Yesilkaya A, Asena L, Gur-Gungor S, et al.
Infect Dis Clin Microbiol . 2024 Apr; 5(1):40-48. PMID: 38633906
Objective: Candidemia is the most common form of invasive candidiasis, and it is associated with end-organ involvement, prolonged hospitalization, increased mortality, and higher healthcare costs. Candidemia can lead to metastatic...
5.
Sari N, Yanik Yalcin T, Erol C, Kurt Azap O, Arslan H, Karakaya E, et al.
Exp Clin Transplant . 2024 Feb; 22(Suppl 1):160-166. PMID: 38385390
Objectives: Solid-organ transplant recipients have high rates of invasive fungal infections. Candida species are the most commonly isolated fungi. Our aim was to identify risk factors, clinical presentations, and outcomes...
6.
Yanik Yalcin T, Sari N, Sarikas C, Erol C, Azap O, Arslan H, et al.
Exp Clin Transplant . 2024 Feb; 22(Suppl 1):153-159. PMID: 38385389
Objectives: Bloodstream infections caused by carbapenem-resistant bacteria have increased globally. Solid-organ transplant recipients are more prone to these infections. This study aimed to compare the clinical courses of carbapenem-susceptible and...
7.
Sari N, Erol C, Yanik Yalcin T, Kurt Azap O, Arslan H, Karakaya E, et al.
Exp Clin Transplant . 2023 Oct; 21(9):764-771. PMID: 37885293
Objectives: Herpes zoster infections can be complicated and mortal in solid-organ transplant recipients. In our study, we investigated herpes zoster infections in solid-organ transplant recipients. Materials And Methods: UntilJune 2022,...
8.
Erol C, Yanik Yalcin T, Sari N, Bayraktar N, Ayvazoglu Soy E, Colak M, et al.
Exp Clin Transplant . 2021 Dec; 19(12):1334-1340. PMID: 34951350
Objectives: Vaccination against SARS-CoV-2 may reduce COVID-19 mortality and complications in solidorgan transplant recipients, and we evaluated the associated antibody responses and adverse effects in this high-risk population. Materials And...
9.
Cubukcu H, Topcu D, Bayraktar N, Gulsen M, Sari N, Arslan A
Am J Clin Pathol . 2021 Nov; 157(5):758-766. PMID: 34791032
Objectives: The present study aimed to develop a clinical decision support tool to assist coronavirus disease 2019 (COVID-19) diagnoses with machine learning (ML) models using routine laboratory test results. Methods:...
10.
Yalcin T, Topcu D, Dogan O, Aydin S, Sari N, Erol C, et al.
J Med Virol . 2021 Sep; 94(1):279-286. PMID: 34468990
Vaccines have been seen as the most important solution for ending the coronavirus disease 2019 (COVID-19) pandemic. The aim of this study is to evaluate the antibody levels after inactivated...